Barclays PLC Hookipa Pharma Inc. Transaction History

Barclays PLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.73 - $14.6 $4,217 - $84,344	-5,777 Reduced 67.77%	2,747 $2,000
Q2 2022 Aug 12, 2022	SELL	$1.33 - $2.31 $4,149 - $7,207	-3,120 Reduced 26.79%	8,524 $14,000
Q1 2022 May 16, 2022	SELL	$1.26 - $2.52 $25,424 - $50,848	-20,178 Reduced 63.41%	11,644 $26,000
Q4 2021 Feb 14, 2022	BUY	$2.33 - $5.94 $36,007 - $91,796	15,454 Added 94.42%	31,822 $74,000
Q3 2021 Nov 09, 2021	BUY	$5.89 - $9.35 $82,100 - $130,329	13,939 Added 573.86%	16,368 $96,000
Q2 2021 Aug 13, 2021	SELL	$9.16 - $19.51 $167,206 - $356,135	-18,254 Reduced 88.26%	2,429 $22,000
Q1 2021 May 13, 2021	BUY	$10.64 - $14.7 $85,173 - $117,673	8,005 Added 63.14%	20,683 $278,000
Q4 2020 Feb 11, 2021	SELL	$9.32 - $13.63 $15,396 - $22,516	-1,652 Reduced 11.53%	12,678 $141,000
Q3 2020 Nov 12, 2020	SELL	$8.59 - $11.89 $9,010 - $12,472	-1,049 Reduced 6.82%	14,330 $135,000
Q2 2020 Aug 12, 2020	BUY	$7.23 - $12.1 $87,237 - $145,998	12,066 Added 364.2%	15,379 $179,000
Q1 2020 May 13, 2020	SELL	$5.9 - $13.8 $39,276 - $91,866	-6,657 Reduced 66.77%	3,313 $28,000
Q4 2019 Feb 10, 2020	BUY	$6.51 - $12.23 $56,903 - $106,902	8,741 Added 711.23%	9,970 $122,000
Q3 2019 Nov 14, 2019	SELL	$6.45 - $8.44 $12,983 - $16,989	-2,013 Reduced 62.09%	1,229 $10,000
Q2 2019 Aug 14, 2019	BUY	$6.16 - $14.15 $19,970 - $45,874	3,242 New	3,242 $22,000

677K

Ticker HOOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,654,500
Market Cap $98.7M
Description
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transpl...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.